Dr. John M. Dye Jr., Viral Immunology branch chief, works in the laboratory at the U.S. Army Medical Research Institute ... - Department of Defense

Details
Written by: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
Parent Category: Medical News
Category: Pathology

Dr. John M. Dye Jr., Viral Immunology branch chief, works in the laboratory at the U.S. Army Medical Research Institute of Infectious Diseases in Frederick, Maryland. Dye is leading a team that is conducting a study with nonhuman primates involving the experimental drug ZMapp, an experimental treatment for Ebola patients. USAMRIID scientists here have worked for years on earlier versions of the Mapp Biopharmaceuticals cocktail of three different monoclonal antibodies. The drug is in Phase 1 clinical trials, but has not yet has completed testing in people for safety or effectiveness. USAMRIID photo

SHARE IMAGE:

Content Original Link:

https://www.defense.gov/Multimedia/Photos/igphoto/2001104231/

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.

Fox Rothschild LLP manages insurance contracts, hospital appointments, transportation, accessibility, and nursing options for new VirusTC patients.